trending Market Intelligence /marketintelligence/en/news-insights/trending/yikmorrik4eafzp1ov2wiw2 content esgSubNav
In This List

Provention Bio appoints director

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Provention Bio appoints director

Provention Bio Inc. added Avery Catlin to its board.

Catlin was previously the senior vice president and CFO of Celldex Therapeutics Inc., a Hampton, N.J.-based biopharmaceutical company that develops immunotherapy technologies and other cancer-targeting biologics.

Oldwick, N.J.-based Provention Bio develops and commercializes novel therapeutics to treat and prevent immune-mediated diseases.